pamidronate has been researched along with enclomiphene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ammann, P; Bonjour, JP; Bourrin, S; Brunner, F; Meyer, JM; Rizzoli, R | 1 |
| Ammann, P; Bonjour, JP; Bourrin, S; Rizzoli, R | 1 |
3 other study(ies) available for pamidronate and enclomiphene
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats.
Topics: Analysis of Variance; Animals; Biomechanical Phenomena; Bone Diseases, Metabolic; Bone Remodeling; Clomiphene; Diphosphonates; Female; Insulin-Like Growth Factor I; Organ Size; Ovariectomy; Pamidronate; Random Allocation; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tibia; Uterus | 1999 |
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
Topics: Aging; Animals; Biomechanical Phenomena; Bone Density; Bone Remodeling; Clomiphene; Diphosphonates; Female; Organ Size; Ovariectomy; Pamidronate; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tibia | 2002 |